Amin Shahrbaf, Mohammad, Monireh Samimi, Shahedeh Karimi, Mehri Salari, Mehran Ghaffari, Sepideh Yazdanbakhsh, Abbas Najafian, Massoud Vosough, and Seyed Massood Nabavi. “The First Study of Real-World Efficacy and Safety of Natalizumab (Tysabri®) in Iran”. Trends in Immunotherapy 8, no. 1 (March 12, 2024). Accessed April 3, 2025. https://ojs.ukscip.com/index.php/ti/article/view/476.